Matthew Hewitt

Stock Analyst at Craig-Hallum

(1.92)
# 3,042
Out of 4,761 analysts
2
Total ratings
50%
Success rate
6.51%
Average return

Stocks Rated by Matthew Hewitt

Lifecore Biomedical
Nov 22, 2024
Maintains: Buy
Price Target: $8$10
Current: $5.61
Upside: +78.25%